Patanjali: India’s controversial superfood empire under fire

Stock Exchange Company Promotes Cow Urine’s Healing Powers for Cancer Treatment in India, prompting Judicial Involvement

In recent years, the Indian food company Patanjali has faced criticism for its wild claims about its products. The company, which is listed on the Mumbai Stock Exchange and known for its aggressive advertising, has been called out for making false claims in advertisements. This includes saying that cow urine cures cancer and tea made from natural herbs is the only cure for corona.

One incident that brought attention to Patanjali was when Ramdev criticized Western medicine in ads, calling it “stupid and bankrupt.” Despite its success, Patanjali has faced criticism for the quality and safety of its products, as well as accusations of having close ties to the Indian government, particularly the ruling BJP party.

Patanjali is not a small company; it is actually the second largest consumer goods company in India after Hindustan Unilever. The company has received investments from international companies like American GQG and rumored interest from French luxury company LVMH. Ramdev, the co-founder of Patanjali, started the business based on Indian medicine principles like Ayurveda and has expanded it into a successful chain of stores across India and in at least 15 other countries.

Despite its successes, Patanjali has faced scrutiny over advertising messages from India’s Supreme Court, which intervened and issued warnings to the company for making false claims. The Modi government in India has been supportive of promoting Indian forms of medicine and yoga, which has benefited companies like Patanjali. However, this shift towards regulation could have a significant impact on future profits and practices for this faith-based medicine sector in India.

Leave a Reply